Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations

Rondaan, Christien, Furer, Victoria, Heijstek, Marloes W, Agmon-Levin, Nancy, Bijl, Marc, Breedveld, Ferdinand C, D’Amelio, Raffaele, Dougados, Maxime, Kapetanovic, Meliha C, van Laar, Jacob M, Ladefoged de Thurah, Annette, Landewé, Robert, Molto, Anna, Müller-Ladner, Ulf, Schreiber, Karen, Smolar, Leo, Walker, Jim, Warnatz, Klaus, Wulffraat, Nico M, van Assen, Sander, Elkayam, Ori·2019·RMD Open
DOI 10.1136/rmdopen-2019-001035

Cites (213)

Items 201–213 of 213

  1. Influenza vaccine with adjuvant on disease activity in psoriatic arthritis patients under anti-TNF-α therapy.
    Francesco Caso, Roberta Ramonda, Antonio DEL PUENTE et al. · 2016 · PubMed
  2. Decreased cell‐mediated cytotoxicity against virus‐infected cells in systemic lupus erythematosus
    Vincent G. Pons, James L. Reinertsen, Alfred D. Steinberg · 1979 · Journal of Medical Virology
  3. Reevaluation of antibody titers 1 year after influenza vaccination in patients with rheumatoid arthritis receiving TNF blockers
    Tokiko Nii, Tetsuo Kubota, Toshihiro Nanki, Yukiko Komano, Masayoshi Harigai, Hitoshi Kohsaka, Wataru Hirose, Kenji Nagasaka, Tetsushi Sakurai, Nobuyuki Miyasaka · 2008 · Modern Rheumatology
  4. Pandemic non-adjuvanted influenza A H1N1 vaccine in a cohort of patients with systemic sclerosis
    Percival Degrava Sampaio-Barros, DANIELI CASTRO OLIVEIRA DE ANDRADE, Luciana Parente Costa Seguro et al. · 2017 · Lara D. Veeken
  5. Factors of the epidemiological triad that influence the persistence of human papilloma virus infection in women with systemic lupus erythematosus
    Socorro Méndez‐Martínez, Mario García‐Carrasco, Erick Alejandro Jiménez-Herrera et al. · 2018 · Lupus
  6. Investigation of clinical characteristics as predictive factors for the humoral immune response to the influenza vaccine in patients with rheumatoid arthritis
    Toshiaki Kogure, Naoyuki Harada, Takeshi Tatsumi, Hiroshi Fujinaga · 2014 · Clinical Rheumatology
  7. Effect of disease-modifying antirheumatic drug therapy on immune response to trivalent influenza vaccine in rheumatoid arthritis
    Vikramraj K. Jain, Nandhini Bhashini, Karthik Balajee Laksham, Sujatha Sistla, Subhash Chandra Parija, Vir Singh Negi · 2017 · The Indian Journal of Medical Research
  8. Pandemic influenza immunization in primary antiphospholipid syndrome (PAPS): a trigger to thrombosis and autoantibody production?
    Dina Medeiros, Clóvis A. Silva, Carolina Tosin Bueno · 2014 · Lupus
  9. Further Evidence for Influenza and Pneumococcal Vaccination in Patients Treated with Disease Modifying Antirheumatic Drugs and Anti-Tumor Necrosis Factor Agents
    Meliha Crnkic Kapetanovic · 2014 · The Journal of Rheumatology
  10. The effect of history of abnormal pap smear or preceding HPV infection on the humoral immune response to Quadrivalent Human Papilloma virus (qHPV) vaccine in women with systemic lupus erythematosus
    J. Patricia Dhar, Lynnette Essenmacher, Renee Dhar · 2018 · Human Vaccines & Immunotherapeutics
  11. FRI0658 INCIDENCE AND PREVALENCE OF VACCINE PREVENTABLE INFECTIONS IN ADULT PATIENTS WITH AUTOIMMUNE INFLAMMATORY RHEUMATIC DISEASES (AIIRD): A SYSTEMIC LITERATURE REVIEW INFORMING THE 2019 UPDATE OF THE EULAR RECOMMENDATIONS FOR VACCINATION IN ADULT PATIENTS WITH AIIRD
    Victoria Furer, Christien Rondaan, Marloes W Heijstek · 2019 · Annals of the Rheumatic Diseases
  12. The Observation of Humoral Responses after Influenza Vaccination in Patients with Rheumatoid Arthritis Treated with Japanese Oriental (Kampo) Medicine: An Observational Study
    Toshiaki Kogure, Naoyuki Harada, Yuko Oku, Takeshi Tatsumi, Atsushi Niizawa · 2012 · Evidence-based Complementary and Alternative Medicine
  13. T.21. TNF Alpha Blockade Impairs T Cell Dependent Antibody Responses
    Gabriela Franco Salinas, Leen De Rycke, Tineke Cantaert · 2009 · Clinical Immunology